Abstract
BackgroundInterstitial lung disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc). However, the severity of lung involvement can vary widely, and current evidence-based treatment options...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
